Abstract: The invention relates to a multilingual method for summarizing an article, which comprises an offline stage in which a weights vector is determined using, among others, plurality of predefined metrics, a collection of documents and expert prepared summaries, subjection of all the document sentences to all said metrics, guess of a population of weights matrices, subjection of the population to said metrics, ranking of sentences, generation of a new population using a genetic algorithm, and repetition of the same until convergence. The invention further comprises a real time stage in which the weights vector, as determined, as well as said metrics are used to determine an extract of any new document.
Type:
Grant
Filed:
July 25, 2011
Date of Patent:
November 26, 2013
Assignee:
Ben-Gurion University of the Negev Research and Development Authority
Inventors:
Marina Litvak, Mark Last, Menahem Friedman
Abstract: The present invention provides anion exchange membranes, processes for producing same and uses thereof. The anion exchange membranes according to embodiments of the present invention achieve a desirable combination of low resistance, high permselectivity and low degree of dimensional swelling. Anion exchange membranes according to embodiments of the present invention are also cost effective.
Type:
Application
Filed:
December 12, 2011
Publication date:
November 7, 2013
Applicant:
Ben-Gurion University of the Negev Research and Development Authority
Inventors:
Charles Linder, Ora Kedem, Rami Messalem
Abstract: A method of preventing and/or treating S. pneumoniae infection in mammalian subjects, wherein said method comprises administering to said subjects a composition comprising one or more agents that are capable of inhibiting the binding of the S. pneumoniae cell wall protein FBA to the respiratory tract cells of said subject.
Type:
Grant
Filed:
September 29, 2008
Date of Patent:
November 5, 2013
Assignees:
Ben-Gurion University of the Negev Research and Development Authority, Mor Research Applications Ltd.
Abstract: Apparatus for detection of human falls comprises: an acceleration detector, for detecting vibration events, typically placed on a floor, a microphone, located in association with the acceleration detector for detection of corresponding sound events, and a classification unit to classify concurrent events from the microphone and the acceleration detector, thereby to determine whether a human fall is indicated. If the event appears to be a human fall, then an alarm is raised.
Type:
Grant
Filed:
April 23, 2012
Date of Patent:
October 1, 2013
Assignees:
Ramot at Tel-Aviv University Ltd., Ben-Gurion University of the Negev Research and Development Authority
Inventors:
Israel Gannot, Dimitry Litvak, Yaniv Zigel
Abstract: A therapeutic composition for treatment of a body tissue which includes an aqueous solution of a cross-linked polymer being capable of: (i) maintaining a liquid state in storage at room temperature for at least 24 hours; and (ii) assuming a gel state following deposition within the body tissue. The therapeutic composition can be effectively administered into a damaged body tissue via injection or catheterization, thereby treating the damaged body tissue.
Abstract: An SRAM memory cell with an internal supply feedback loop is provided herein. The memory cell includes a latch that has a storage node Q, a storage node QB, a supply node, and a ground node. The supply node is coupled via a gating device to a supply voltage and ground node is connected to ground. In addition, storage node Q is fed back via feedback loop into a control node of the gating device. In operation, writing into the memory cell may be carried out in a similar manner to dual port SRAM cells, utilizing one or two write circuitries and for writing into storage node Q and storage node QB respectively. Differently from standard SRAM cells, the feedback loop, by controlling the gating device is configured to weaken the write contention.
Type:
Grant
Filed:
May 8, 2011
Date of Patent:
September 10, 2013
Assignee:
Ben-Gurion University of the Negev Research and Development Authority
Inventors:
Adam Teman, Lidor Pergament, Omer Cohen, Alexander Fish
Abstract: Sulfur chelated ruthenium compounds represented by the following formula: wherein M indicates the ruthenium metal bound to a benzylidene carbon; R represents C1-C7 alkyl group or optionally substituted aryl; X1 and X2 each independently represent halogen; Y1 and Y2 each independently denote unsubstituted or alkyl-substituted phenyl; and Z independently represents hydrogen, electron withdrawing or electron donating substituent, with m being an integer from 1 to 4, and processes and compositions related thereto.
Type:
Grant
Filed:
October 30, 2009
Date of Patent:
August 20, 2013
Assignee:
Ben-Gurion University of the Negev Research and Development Authority
Abstract: The invention provides pyrrolidino-substituted 1,4-naphthoquinone derivatives that modulate the activity of protein kinases, and it relates to the use of the derivatives in pharmaceutical compositions for treating cardiovascular disorders and malignancies. The invention particularly provides medicaments for treating disorders associated with MAPKs signaling, ERKs signaling, p38 signaling, and JNKs signaling.
Type:
Grant
Filed:
July 21, 2005
Date of Patent:
August 20, 2013
Assignee:
Ben Gurion University of the Negev Research and Development Authority
Abstract: This invention is directed, inter alia, to methods and kits for rapid, easy and cost-effective methods of breast cancer prediction and diagnosis in inter alia, blood samples.
Type:
Application
Filed:
October 24, 2012
Publication date:
July 25, 2013
Applicants:
Mor Research Application Ltd., Ben Gurion University of the Negev Research and Development Authority
Inventors:
Ben Gurion University of the Negev Research and, Mor Research Application Ltd.
Abstract: A polymer electrolyte membrane (PEM) for fuel cells is provided, as well as a method for manufacturing the PEM by direct casting on the fuel cells electrodes. The PEM, consisting of an ionic liquid entrapped within polysiloxane-RTV matrix, is stable at high temperatures, in acidic and basic environments, and exhibits a high conductivity, without the crossover of methanol.
Type:
Grant
Filed:
December 22, 2006
Date of Patent:
July 23, 2013
Assignee:
Ben Gurion University of the Negev Research & Development Authority
Abstract: A method of forming a nanowire structure is disclosed. The method comprises applying on a surface of carrier liquid a layer of a liquid composition which comprises a surfactant and a plurality of nanostructures each having a core and a shell, and heating at least one of the carrier liquid and the liquid composition to a temperature selected such that the nanostructures are segregated from the surfactant and assemble into a nanowire structure on the surface.
Type:
Grant
Filed:
April 8, 2010
Date of Patent:
June 25, 2013
Assignee:
Ben Gurion University of the Negev Research and Development Authority
Abstract: A therapeutic composition for treatment of a body tissue which includes an aqueous solution of a cross-linked polymer being capable of: (i) maintaining a liquid state in storage at room temperature for at least 24 hours; and (ii) assuming a gel state following deposition within the body tissue. The therapeutic composition can be effectively administered into a damaged body tissue via injection or catheterization, thereby treating the damaged body tissue.
Type:
Grant
Filed:
March 26, 2012
Date of Patent:
June 11, 2013
Assignee:
Ben Gurion University of the Negev Research and Development Authority
Abstract: A therapeutic composition for treatment of a body tissue which includes an aqueous solution of a cross-linked polymer being capable of: (i) maintaining a liquid state in storage at room temperature for at least 24 hours; and (ii) assuming a gel state following deposition within the body tissue. The therapeutic composition can be effectively administered into a damaged body tissue via injection or catheterization, thereby treating the damaged body tissue.
Type:
Grant
Filed:
March 26, 2012
Date of Patent:
June 4, 2013
Assignee:
Ben Gurion University of the Negev Research and Development Authority
Abstract: There are provided herein selective membranes, such as composite membranes, and/or films and processes for their preparation. The membranes and/or films have a given morphology which may be stabilized, for example against swelling and chemical degradation, by covalent crosslinking and optionally, in addition, by hydrophobization. There is provided a membrane and/or film and a process for the preparation thereof, the membrane and/or film include an ionomer and/or polyelectrolyte crosslinked through aryl-aryl (—Ar—Ar—), aryl-ether-aryl (—Ar—O—Ar—) and/or aryl-sulfide-aryl (—Ar—S—Ar—) bonds.
Type:
Grant
Filed:
May 24, 2007
Date of Patent:
June 4, 2013
Assignee:
Ben Gurion University of the Negev R&D Authority
Abstract: The invention is an apparatus and method for free space pumping of active double-clad fiber based lasers and amplifiers. The apparatus comprises a laser emitting a signal laser beam; an active double-clad fiber having a core defining an optical axis of the apparatus and a pump cladding defining a cone of numerical aperture; an optical arrangement directing the signal laser beam along the optical axis through the core of the active double-clad fiber; at least one pump source emitting a pump beam; at least one delivery means coupling the pump beam to the pump cladding of the active double-clad fiber; and an optical arrangement coupling the amplified signal laser beam exiting the active double-clad fiber out of the apparatus.
Type:
Application
Filed:
July 30, 2010
Publication date:
May 23, 2013
Applicant:
Ben-Gurion University of The Negev Research and De Authority
Abstract: Provided is a formulation containing amorphous or microcrystalline calcium carbonate finely interspersed with organic matter in a ratio of 10 parts of the carbonate per 1 to 3 parts of the organic matter, wherein the organic matter consists of chitin and polypeptide. The formulation is efficient in treating various pathological conditions, including proliferative diseases, neurological disorders, and musculoskeletal disorders.
Type:
Application
Filed:
December 27, 2012
Publication date:
May 16, 2013
Applicants:
Ben-Gurion University of the Negev Research and Development Authority
Inventors:
Ben-Gurion University of the Negev Research and Development Authority, Yossi Ben
Abstract: The present invention relates to a nucleic acid molecule encoding an insulin-like factor of the androgenic gland of the freshwater prawn Macrobrachium rosenbergii (M. rosenbergii). The present invention further relates to methods of silencing the expression of the insulin-like factor gene in decapod crustaceans order, particularly in M. rosenbergii, useful for producing male monosex populations.
Type:
Grant
Filed:
October 19, 2011
Date of Patent:
May 14, 2013
Assignee:
Ben-Gurion University of the Negev Research and Development Authority
Abstract: The present invention relates generally to variants and peptides of the mitochondrial protein, voltage-dependent anion channel (VDAC) and to polynucleotides encoding same. In particular, the present invention is directed to N-terminal truncated and mutated VDAC and specific amino acid and polynucleotide sequences thereof useful in inhibiting apoptosis, and to pharmaceutical compositions comprising same useful in the treatment of diseases associated with excess apoptosis.
Type:
Grant
Filed:
April 10, 2007
Date of Patent:
May 14, 2013
Assignee:
Ben-Gurion University of The Negev Research and Development Authority Ltd.
Abstract: A method of treating a patient suffering from a disease characterized by tissue necrosis by administering to the patient a necrosis inhibitor and/or a Humanin or a derivative of Humanin is provided. The invention further includes a method for prophylactically treating a patient at risk for a pathological condition that is precipitated at least in part by tissue necrosis by administering to the patient a necrosis inhibitor and/or a Humanin or a derivative of Humanin.
Type:
Application
Filed:
February 23, 2011
Publication date:
May 2, 2013
Applicant:
Ben Gurion University of the Negev Research and Development Authority
Inventors:
Abraham Parola, Ilana Nathan, Ron Kasher, Jenny Lerner Yardeni, Aviv Cohen
Abstract: Vaccine compositions and methods for protecting a mammalian subject against infection with S. pneumoniae are disclosed. The vaccines and methods comprise an effective amount of one or more Streptococcus pneumoniae cell wall and/or cell membrane proteins and/or immunogenically-active fragments, derivatives or modifications thereof, wherein the proteins are selected from a defined group of proteins associated with age-dependent immunological responses.
Type:
Application
Filed:
January 4, 2013
Publication date:
May 2, 2013
Applicant:
Ben-Gurion University of the Negev Research and Development Authority
Inventor:
Ben-Gurion University of the Negev Research and Development Authority